M&A Update – Dec 11

– PDCO to be acquired by Patient Square Capital for $31.35 cash per share, 43.3% premium, $4.1 billion
– K / Mars cleared Competition Canada
– ACI / KR merger blocked by U.S. judge, deal terminated
– PFC / WSBC votes